345 related articles for article (PubMed ID: 19826108)
41. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
Moffat FL
J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
[No Abstract] [Full Text] [Related]
42. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
43. Axillary reverse mapping (ARM): where to go.
Shao X; Sun B; Shen Y
Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238
[TBL] [Abstract][Full Text] [Related]
44. Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction.
Sclafani LM; Baron RH
Cancer J; 2008; 14(4):216-22. PubMed ID: 18677128
[TBL] [Abstract][Full Text] [Related]
45. The Veronesi quadrantectomy: an established procedure for the conservative treatment of early breast cancer.
Zurrida S; Costa A; Luini A; Galimberti V; Sacchini V; Intra M
Int J Surg Investig; 2001; 2(6):423-31. PubMed ID: 12678123
[TBL] [Abstract][Full Text] [Related]
46. 5-year follow-up after sentinel node mapping for breast cancer demonstrates better than expected treatment outcomes.
Fuhrman GM; Gambino J; Bolton JS; Farr G; Jiang X
Am Surg; 2005 Jul; 71(7):564-9; discussion 569-70. PubMed ID: 16089119
[TBL] [Abstract][Full Text] [Related]
47. Non-axillary breast cancer recurrences after sentinel node biopsy.
van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
[TBL] [Abstract][Full Text] [Related]
48. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
50. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
51. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
52. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
Golshan M; Martin WJ; Dowlatshahi K
Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
[TBL] [Abstract][Full Text] [Related]
53. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
Johnson J; Esserman L; Ewing C; Alvarado M; Park C; Fowble B
Ann Surg Oncol; 2016 Mar; 23(3):715-21. PubMed ID: 26714943
[TBL] [Abstract][Full Text] [Related]
54. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer.
Choi YJ; Yun HR; Yoo KE; Kim JH; Nam SJ; Choi YL; Ko YH; Kim BT; Yang JH
Jpn J Clin Oncol; 2006 Aug; 36(8):489-93. PubMed ID: 16790449
[TBL] [Abstract][Full Text] [Related]
55. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
56. Management of abnormal Rotter's lymph nodes identified on preoperative breast magnetic resonance imaging.
Kiluk JV; Khakpour N; Lee MC; Lowe J; Harris E; Szabunio M; Laronga C
Am Surg; 2011 Jan; 77(1):E10-2. PubMed ID: 21396292
[No Abstract] [Full Text] [Related]
57. How to handle positive sentinel nodes?
Schmidt C
J Natl Cancer Inst; 2010 Dec; 102(24):1820-1, 1823. PubMed ID: 21139099
[No Abstract] [Full Text] [Related]
58. Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.
Gauthier T; Garuchet-Bigot A; Marin B; Mollard J; Loum O; Fermeaux V; Jammet I; Kanoun D; Maubon A; Aubard Y
Eur J Surg Oncol; 2012 Oct; 38(10):902-9. PubMed ID: 22703757
[TBL] [Abstract][Full Text] [Related]
59. Sentinel lymph node biopsy in breast cancer: cure and survival are paramount.
Moffat FL
J Surg Oncol; 2010 Aug; 102(2):109-10. PubMed ID: 20648578
[No Abstract] [Full Text] [Related]
60. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
